Ligand Pharmaceuticals, Inc.
ISIN US53220K5048
|WKN A1C9RN
| Invest in ETFs without Lightyear execution fees. | Capital at risk. Other fees and T&C apply. Overview
Description
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Healthcare Biopharmaceuticals Other Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 2,088.95 m |
| EPS, EUR | 2.32 |
| P/B ratio | 2.62 |
| P/E ratio | 46.65 |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 121.46 m |
| Net income, EUR | 49.78 m |
| Profit margin | 40.98% |
What ETF is Ligand Pharmaceuticals, Inc. in?
There are 28 ETFs which contain Ligand Pharmaceuticals, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Ligand Pharmaceuticals, Inc. is the L&G Pharma Breakthrough UCITS ETF.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc) | 0.04% | Equity United States Small Cap | 1,374 | 0.14% | 60 | +25.62% | A3DQ08 | IE000JNKVS10 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to EUR) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,919 | 0.28% | 7 | +18.47% | A2DWAC | IE00BDGV0746 |
| iShares S&P SmallCap 600 UCITS ETF | 0.14% | Equity United States Small Cap | 603 | 0.30% | 3,048 | +19.99% | A0Q1YY | IE00B2QWCY14 |
| L&G Russell 2000 US Small Cap Quality UCITS ETF | 0.08% | Equity United States Small Cap | 1,021 | 0.30% | 228 | +22.71% | A0Q8H2 | IE00B3CNHJ55 |
| iShares Healthcare Innovation UCITS ETF | 0.25% | Equity World Health Care Social/Environmental Innovation | 192 | 0.40% | 1,035 | +13.95% | A2ANH2 | IE00BYZK4776 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.04% | Equity United States Small Cap | 1,374 | 0.14% | 177 | +26.06% | A3DQ09 | IE0001O84583 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-dis | 0.01% | Equity United States Multi-Factor Strategy | 1,919 | 0.25% | 34 | +25.56% | A2DND0 | IE00BDGV0308 |
| L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.50% | Equity World Social/Environmental Innovation | 366 | 0.60% | 4 | +17.53% | A3DHPA | IE000VTOHNZ0 |
| L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing | 0.01% | Equity World Multi-Factor Strategy | 3,700 | 0.50% | 77 | +22.33% | WELT0B | IE000FPWSL69 |
| iShares MSCI World Small Cap UCITS ETF | 0.02% | Equity World Small Cap | 3,316 | 0.35% | 4,929 | +20.32% | A2DWBY | IE00BF4RFH31 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Accumulating | 0.00% | Equity North America Social/Environmental | 1,494 | 0.12% | 268 | +28.81% | A3DJRE | IE000O58J820 |
| SPDR Russell 2000 US Small Cap UCITS ETF | 0.07% | Equity United States Small Cap | 1,784 | 0.30% | 4,926 | +23.12% | A1XFN1 | IE00BJ38QD84 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,919 | 0.25% | 87 | +25.54% | A2JSD1 | IE00BDGV0415 |
| SPDR MSCI World Small Cap UCITS ETF | 0.02% | Equity World Small Cap | 3,544 | 0.45% | 952 | +19.86% | A1W56P | IE00BCBJG560 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% | Equity World Social/Environmental | 5,826 | 0.24% | 426 | +24.61% | A2QL8V | IE00BNG8L385 |
| Xtrackers Russell 2000 UCITS ETF 1C | 0.07% | Equity United States Small Cap | 1,498 | 0.30% | 2,183 | +22.94% | A1XEJT | IE00BJZ2DD79 |
| First Trust US IPO Index UCITS ETF Acc | 0.08% | Equity United States IPO | 100 | 0.65% | 8 | +44.65% | A14X88 | IE00BYTH6238 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to CHF) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,919 | 0.28% | 25 | +14.78% | A2DWAB | IE00BDGV0C91 |
| iShares MSCI USA Small Cap ESG Enhanced UCITS ETF (Acc) | 0.01% | Equity United States Small Cap | 1,598 | 0.43% | 2,395 | +22.54% | A0X8SB | IE00B3VWM098 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.20% | Equity United States Health Care Biotech | 265 | 0.35% | 31 | +9.21% | A2JDYM | IE00BDZVHG35 |
| L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating | 0.01% | Equity World Multi-Factor Strategy | 3,700 | 0.50% | 422 | +22.73% | WELT0A | IE0001UQQ933 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.20% | Equity United States Health Care Biotech | 265 | 0.35% | 461 | +8.58% | A2DWAW | IE00BYXG2H39 |
| SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.01% | Equity United States Small Cap | 1,731 | 0.30% | 590 | +22.76% | A12HU5 | IE00BSPLC413 |
| iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) | 0.01% | Equity World Small Cap | 2,528 | 0.35% | 61 | +19.39% | A3C14G | IE000T9EOCL3 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.00% | Equity North America Social/Environmental | 1,494 | 0.12% | 30 | +29.23% | A3DJRF | IE000L2ZNB07 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating | 0.00% | Equity World Social/Environmental | 5,826 | 0.24% | 489 | +24.71% | A2QL8U | IE00BNG8L278 |
| Amundi S&P SmallCap 600 ESG UCITS ETF Dist | 0.25% | Equity United States Small Cap | 359 | 0.35% | 440 | +21.07% | ETF039 | IE000XLJ2JQ9 |
| L&G Pharma Breakthrough UCITS ETF | 3.07% | Equity World Health Care Innovation | 37 | 0.49% | 18 | +12.44% | A2H9XR | IE00BF0H7608 |
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.